Clinical trial
A Crossover Study in the Treatment of Patients With COPD
NCT00462540 · Dey, Industry · Completed
Key facts
| NCT number | NCT00462540 |
|---|---|
| Title | A Crossover Study in the Treatment of Patients With COPD |
| Lead sponsor | Dey, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug |
| Interventions | Formoterol Fumurate inhalation solution 20 mcg, Ipratropium bromide 18 mcg and albuterol sulfate 103 mcg |
| Enrollment | 100 |
| Start date | May 1, 2007 |
| Primary completion | Sep 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Apr 19, 2007 |
| Last update posted | Mar 4, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: